![Dawn Bell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Dawn Bell is currently working as a Director at STRM.Bio, Inc. She obtained a doctorate degree from the University of Florida.
Actieve functies van Dawn Bell
Bedrijven | Functie | Begin |
---|---|---|
STRM.Bio, Inc.
![]() STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Directeur/Bestuurslid | 17-05-2023 |
Opleiding van Dawn Bell
University of Florida | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
STRM.Bio, Inc.
![]() STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Health Technology |